Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Yeh

Showing results (791-800 of 837) with videos related to

Pageof 84
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Discovery of orally active butyrolactam 11beta-HSD1 inhibitorsVince S C Yeh, Ravi Kurukulasuriya, Steven Fung, et al.
British Journal of Cancer|October 5, 2020
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancerBenjamin C Creelan, Tammie C Yeh, Sang-We Kim, et al.
Molecular Cancer Therapeutics|October 22, 2017
AKT1<sup>low</sup> Quiescent Cancer Cells Promote Solid Tumor GrowthCleidson P Alves, Ipsita Dey-Guha, Sheheryar Kabraji, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 17, 2019
Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profilingAlbert C Yeh, Hui Li, Yitan Zhu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 22, 2013
Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trialR R Rubin, M Peyrot, N-Y Wang, et al.
Transplantation Proceedings|March 14, 2012
A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantationK-S Poon, T-H Chen, L-B Jeng, et al.
Bone Marrow Transplantation|November 6, 2021
Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulinAlbert C Yeh, Paul V O'Donnell, Gary Schoch, et al.
Transplantation Proceedings|March 14, 2012
Simultaneous liver and kidney transplantation from different living donorsK-S Soh, L-B Jeng, H-R Yang, et al.
Blood|February 9, 2026
Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1 and Th17-dependent GVHD within the Gastrointestinal TractShuichiro Takahashi, Takayuki Inoue, Kathleen S Ensbey, et al.
Journal of Medicinal Chemistry|January 20, 2006
Potent and selective mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors. 1. 4-(4-bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-onesEli M Wallace, Joseph Lyssikatos, James F Blake, et al.
Pageof 84

Showing results (791-800 of 837) with videos related to

Sort By:
Pageof 84
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Discovery of orally active butyrolactam 11beta-HSD1 inhibitorsVince S C Yeh, Ravi Kurukulasuriya, Steven Fung, et al.
British Journal of Cancer|October 5, 2020
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancerBenjamin C Creelan, Tammie C Yeh, Sang-We Kim, et al.
Molecular Cancer Therapeutics|October 22, 2017
AKT1<sup>low</sup> Quiescent Cancer Cells Promote Solid Tumor GrowthCleidson P Alves, Ipsita Dey-Guha, Sheheryar Kabraji, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 17, 2019
Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profilingAlbert C Yeh, Hui Li, Yitan Zhu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 22, 2013
Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trialR R Rubin, M Peyrot, N-Y Wang, et al.
Transplantation Proceedings|March 14, 2012
A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantationK-S Poon, T-H Chen, L-B Jeng, et al.
Bone Marrow Transplantation|November 6, 2021
Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulinAlbert C Yeh, Paul V O'Donnell, Gary Schoch, et al.
Transplantation Proceedings|March 14, 2012
Simultaneous liver and kidney transplantation from different living donorsK-S Soh, L-B Jeng, H-R Yang, et al.
Blood|February 9, 2026
Targeting donor XCR1+ and CD11b+ dendritic cells prevents Th1 and Th17-dependent GVHD within the Gastrointestinal TractShuichiro Takahashi, Takayuki Inoue, Kathleen S Ensbey, et al.
Journal of Medicinal Chemistry|January 20, 2006
Potent and selective mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors. 1. 4-(4-bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-onesEli M Wallace, Joseph Lyssikatos, James F Blake, et al.
Pageof 84